• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

洗必泰、异噻唑啉酮混合物(“卡松”CG)和十六烷基三甲基溴化铵(CTAB)的体外抗菌活性。

The antimicrobial activity in vitro of chlorhexidine, a mixture of isothiazolinones ('Kathon' CG) and cetyl trimethyl ammonium bromide (CTAB).

作者信息

Nicoletti G, Boghossian V, Gurevitch F, Borland R, Morgenroth P

机构信息

Department of Applied Biology & Biotechnology, Royal Melbourne Institute of Technology, Victoria, Australia.

出版信息

J Hosp Infect. 1993 Feb;23(2):87-111. doi: 10.1016/0195-6701(93)90014-q.

DOI:10.1016/0195-6701(93)90014-q
PMID:8097222
Abstract

Chlorehexidine, two 4% chlorhexidine antiseptic handwashes ('Bioprep' and 'Hibiclens'), cetyl trimethyl ammonium bromide (CTAB) and isothiazolinones ('Kathon') were tested against Staphylococcus aureus, Micrococcus luteus, Escherichia coli, Serratia marcescens, Pseudomonas aeruginosa, Proteus vulgaris and Candida albicans. The activities measured were the minimum inhibitory concentration (MIC), minimum microbicidal concentration (MMC), rate of kill in water and broth, effect of organic soil, the development of microbial resistance on continuous exposure and agent bioavailability in media and formulation. 'Kathon' was the most active microbistatic agent showing maximal activity at low concentration, least inactivation by organic soil and media components and the lowest level of development of bacterial resistance. It was synergistic with chlorhexidine against S. marcescens and P. aeruginosa. Media, formulation components and organic soil affected the performance of chlorhexidine and CTAB. Chlorhexidine was more broadly active than CTAB but showed a greater reduction in activity in the presence of soil and engendered a greater level of bacterial resistance. It was more rapidly bactericidal to P. aeruginosa and S. marcescens than to S. aureus. Stable resistance to chlorhexidine and CTAB was developed by P. aeruginosa and S. marcescens, the latter showing the higher level of resistance. Chlorhexidine-resistant strains were also resistant to CTAB. The antiseptic formulations were more rapidly bactericidal than chlorhexidine alone but were otherwise of comparable activity. Mixtures of disinfectants, in particular a combination of chlorhexidine and a preservative level of 'Kathon', were more active than single disinfectants. The importance of standardization of media and test conditions and the use of chemically defined media for accurate and reproducible in-vitro testing of disinfectant activity is emphasized. Disinfection kinetics, expressed as time-kill curves, log reduction factors or decimal reduction times were shown to be valuable in differentiating microbistatic from microbicidal activity, showing the effects of dilution and soil on activity and indicating possible different mechanisms of action.

摘要

对洗必泰、两种4%的洗必泰消毒洗手液(“Bioprep”和“Hibiclens”)、十六烷基三甲基溴化铵(CTAB)和异噻唑啉酮(“Kathon”)进行了针对金黄色葡萄球菌、藤黄微球菌、大肠杆菌、粘质沙雷氏菌、铜绿假单胞菌、普通变形杆菌和白色念珠菌的测试。所测量的活性包括最低抑菌浓度(MIC)、最低杀菌浓度(MMC)、在水和肉汤中的杀菌速率、有机污垢的影响、持续暴露时微生物耐药性的发展以及在培养基和制剂中的药剂生物利用度。“Kathon”是最具活性的抑菌剂,在低浓度时显示出最大活性,受有机污垢和培养基成分的失活作用最小,细菌耐药性发展水平最低。它与洗必泰对粘质沙雷氏菌和铜绿假单胞菌具有协同作用。培养基、制剂成分和有机污垢会影响洗必泰和CTAB的性能。洗必泰的活性比CTAB更广泛,但在有污垢存在时活性降低幅度更大,且产生的细菌耐药性水平更高。它对铜绿假单胞菌和粘质沙雷氏菌的杀菌速度比对金黄色葡萄球菌更快。铜绿假单胞菌和粘质沙雷氏菌对洗必泰和CTAB产生了稳定的耐药性,后者显示出更高的耐药水平。耐洗必泰菌株对CTAB也耐药。消毒制剂的杀菌速度比单独的洗必泰更快,但在其他方面活性相当。消毒剂混合物,特别是洗必泰和“Kathon”防腐剂量的组合,比单一消毒剂更具活性。强调了培养基和测试条件标准化以及使用化学定义培养基进行消毒剂活性准确且可重复的体外测试的重要性。以时间 - 杀灭曲线、对数减少因子或十进制减少时间表示的消毒动力学在区分抑菌和杀菌活性、显示稀释和污垢对活性的影响以及表明可能不同的作用机制方面被证明是有价值的。

相似文献

1
The antimicrobial activity in vitro of chlorhexidine, a mixture of isothiazolinones ('Kathon' CG) and cetyl trimethyl ammonium bromide (CTAB).洗必泰、异噻唑啉酮混合物(“卡松”CG)和十六烷基三甲基溴化铵(CTAB)的体外抗菌活性。
J Hosp Infect. 1993 Feb;23(2):87-111. doi: 10.1016/0195-6701(93)90014-q.
2
Comparative susceptibility of hospital isolates of gram-negative bacteria to antiseptics and disinfectants.革兰氏阴性菌医院分离株对抗菌剂和消毒剂的敏感性比较
J Hosp Infect. 1987 May;9(3):255-64. doi: 10.1016/0195-6701(87)90122-8.
3
[Bactericial activity of chlorhexidine gluconate against recent clinical isolates of various bacterial species in Japan].[葡萄糖酸氯己定对日本近期临床分离的各种细菌菌株的抗菌活性]
Jpn J Antibiot. 2004 Oct;57(5):449-64.
4
An investigation of the bactericidal effect of certain antiseptics and disinfectants on some hospital isolates of gram-negative bacteria.某些防腐剂和消毒剂对一些医院分离的革兰氏阴性菌的杀菌效果研究。
Infect Control Hosp Epidemiol. 2003 Mar;24(3):225-7. doi: 10.1086/502194.
5
[Antimicrobial and sporicidal efficacy of various disinfectant solutions].[各种消毒剂溶液的抗菌和杀孢子功效]
Minerva Med. 1995 Jan-Feb;86(1-2):21-32.
6
Growth media and assay plate material can impact on the effectiveness of cationic biocides and antibiotics against different bacterial species.生长培养基和检测平板材料会影响阳离子杀菌剂和抗生素对不同细菌种类的有效性。
Lett Appl Microbiol. 2018 May;66(5):368-377. doi: 10.1111/lam.12863. Epub 2018 Mar 22.
7
[Activity of frequently used disinfectants and antiseptics against nosocomial bacterial types].常用消毒剂和防腐剂对医院细菌类型的活性
Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):157-62.
8
Efficacy of chlorhexidine against some strains of cultured and clinically isolated microorganisms.
Vet Res Commun. 2000 May;24(4):229-38. doi: 10.1023/a:1006442715761.
9
Development of an accumulation assay and evaluation of the effects of efflux pump inhibitors on the retention of chlorhexidine digluconate in Pseudomonas aeruginosa and Staphylococcus aureus.建立一种蓄积测定方法,并评估外排泵抑制剂对葡萄糖酸氯己定在铜绿假单胞菌和金黄色葡萄球菌中蓄积的影响。
BMC Res Notes. 2017 Jul 26;10(1):328. doi: 10.1186/s13104-017-2637-2.
10
Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration.铜绿假单胞菌对双醋酸氯己定耐药性的产生及“残留”浓度的影响
J Hosp Infect. 2000 Dec;46(4):297-303. doi: 10.1053/jhin.2000.0851.

引用本文的文献

1
Biocidal and antibiofilm activities of arginine-based surfactants against Candida isolates.基于精氨酸的表面活性剂对分离的念珠菌的杀菌和抗生物膜活性。
Amino Acids. 2023 Sep;55(9):1083-1102. doi: 10.1007/s00726-023-03296-z. Epub 2023 Jun 29.
2
Biocompatibility and biocidal effects of modified polylactide composites.改性聚丙交酯复合材料的生物相容性和杀菌效果
Front Microbiol. 2022 Nov 24;13:1031783. doi: 10.3389/fmicb.2022.1031783. eCollection 2022.
3
Dielectric and Mechanical Properties of CTAB-Modified Natural Rubber Latex-Cement Composites.
十六烷基三甲基溴化铵改性天然橡胶乳胶-水泥复合材料的介电和力学性能
Polymers (Basel). 2022 Jan 13;14(2):320. doi: 10.3390/polym14020320.
4
Antimicrobial stewardship of antiseptics that are pertinent to wounds: the need for a united approach.与伤口相关的防腐剂的抗菌管理:需要统一的方法。
JAC Antimicrob Resist. 2021 Mar 25;3(1):dlab027. doi: 10.1093/jacamr/dlab027. eCollection 2021 Mar.
5
Nystatin effect on chlorhexidine efficacy against Streptococcus mutans as planktonic cells and mixed biofilm with Candida albicans.制霉菌素对氯己定抑制变形链球菌和白色念珠菌混合生物膜的效果的影响。
Clin Oral Investig. 2022 Jan;26(1):633-642. doi: 10.1007/s00784-021-04041-0. Epub 2021 Jun 23.
6
Adaptive bacterial response to low level chlorhexidine exposure and its implications for hand hygiene.细菌对低水平洗必泰暴露的适应性反应及其对手部卫生的影响。
Microb Cell. 2019 Mar 7;6(7):307-320. doi: 10.15698/mic2019.07.683.
7
Surfactants: Role in biofilm management and cellular behaviour.表面活性剂:在生物膜管理和细胞行为中的作用。
Int Wound J. 2019 Jun;16(3):753-760. doi: 10.1111/iwj.13093. Epub 2019 Mar 18.
8
Development of resistance of mutans streptococci and Porphyromonas gingivalis to chlorhexidine digluconate and amine fluoride/stannous fluoride-containing mouthrinses, in vitro.变形链球菌和牙龈卟啉单胞菌对葡萄糖酸洗必泰及含胺氟化物/氟化亚锡漱口水的体外耐药性研究
Clin Oral Investig. 2015 Jul;19(6):1547-53. doi: 10.1007/s00784-014-1379-y. Epub 2014 Dec 9.
9
Antiviral effect of cationic compounds on bacteriophages.阳离子化合物对噬菌体的抗病毒作用。
Front Microbiol. 2013 Mar 12;4:46. doi: 10.3389/fmicb.2013.00046. eCollection 2013.
10
Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance.消费品中增加使用杀生物剂对抗生素耐药性流行的潜在影响。
Clin Microbiol Rev. 2003 Apr;16(2):189-208. doi: 10.1128/CMR.16.2.189-208.2003.